Heska Corp (HSKA) Receives Average Rating of “Hold” from Analysts
Heska Corp (NASDAQ:HSKA) has received an average rating of “Hold” from the nine research firms that are presently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a sell rating, one has given a hold rating and five have assigned a buy rating to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $105.50.
A number of equities research analysts have commented on HSKA shares. Raymond James Financial reissued a “buy” rating on shares of Heska in a report on Monday, December 4th. B. Riley decreased their price objective on shares of Heska from $96.50 to $93.00 and set a “neutral” rating on the stock in a report on Friday, November 3rd. BidaskClub raised shares of Heska from a “sell” rating to a “hold” rating in a report on Thursday, December 21st. Aegis reissued a “buy” rating on shares of Heska in a report on Tuesday, December 19th. Finally, Zacks Investment Research lowered shares of Heska from a “hold” rating to a “sell” rating in a report on Wednesday, January 3rd.
Shares of Heska (NASDAQ:HSKA) traded down $2.16 during trading hours on Wednesday, reaching $58.36. 110,700 shares of the company’s stock were exchanged, compared to its average volume of 79,852. Heska has a 12-month low of $56.59 and a 12-month high of $115.00. The company has a market cap of $420.48, a price-to-earnings ratio of 30.72, a P/E/G ratio of 1.57 and a beta of 0.67.
A number of institutional investors have recently added to or reduced their stakes in HSKA. Royal Bank of Canada lifted its position in Heska by 96.9% during the 2nd quarter. Royal Bank of Canada now owns 1,014 shares of the medical research company’s stock valued at $103,000 after purchasing an additional 499 shares during the period. SG Americas Securities LLC acquired a new stake in shares of Heska in the 3rd quarter valued at approximately $108,000. Quantitative Systematic Strategies LLC acquired a new stake in shares of Heska in the 4th quarter valued at approximately $206,000. Landscape Capital Management L.L.C. acquired a new stake in shares of Heska in the 4th quarter valued at approximately $209,000. Finally, Municipal Employees Retirement System of Michigan raised its position in shares of Heska by 58.9% in the 3rd quarter. Municipal Employees Retirement System of Michigan now owns 2,400 shares of the medical research company’s stock valued at $211,000 after acquiring an additional 890 shares during the period. Institutional investors own 80.03% of the company’s stock.
Heska Corporation sells veterinary diagnostic and specialty products. The Company operates through two segments: Core Companion Animal Health (CCA) and Other Vaccines, Pharmaceuticals and Products (OVP). The CCA segment includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, local and cloud-based data services, allergy testing and immunotherapy, and single use offerings, such as in-clinic diagnostic tests and heartworm preventive products.
Receive News & Ratings for Heska Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Heska and related companies with MarketBeat.com's FREE daily email newsletter.